Last reviewed · How we verify

Iodine Complex

Sohaib Ashraf · FDA-approved active Small molecule ✓ Verified May 2026 Quality 5/100

Iodine Complex is a Small molecule drug developed by Sohaib Ashraf. It is currently FDA-approved.

Iodine Complex is a substance studied in clinical trials for various conditions, including Post-thoracotomy Pain Syndrome, Iodine Deficiency, Surgical Site Infection, Anesthesia, and Malnutrition. It has been used as an intervention in trials, including those involving Povidone-Iodine, but its exact mechanism of action is unknown.

At a glance

Generic nameIodine Complex
SponsorSohaib Ashraf
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Iodine Complex

What is Iodine Complex?

Iodine Complex is a Small molecule drug developed by Sohaib Ashraf.

Who makes Iodine Complex?

Iodine Complex is developed and marketed by Sohaib Ashraf (see full Sohaib Ashraf pipeline at /company/sohaib-ashraf).

What development phase is Iodine Complex in?

Iodine Complex is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing